
Melanotan I
Linear α-MSH analog (afamelanotide sequence) studied in melanogenesis and photoprotection models.
⚠ For research use only · Not for human use · Not FDA approved

Linear α-MSH analog (afamelanotide sequence) studied in melanogenesis and photoprotection models.
⚠ For research use only · Not for human use · Not FDA approved
A short research-handling guide for Melanotan I. For laboratory and research use only.
Linear α-MSH analog (afamelanotide sequence) studied in melanogenesis and photoprotection models.
Melanotan I is supplied as a lyophilized (freeze-dried) powder. Reconstitute it before research use. Recommended diluent: bacteriostatic water.
Example: 2 ml of diluent in this 10 mg vial gives 5,000 mcg/ml. A 500 mcg research amount is then 0.1 ml (10 units on a U-100 syringe) — about 20 doses per vial.
Most commonly referenced in published research at 500–1,000 mcg, once daily. Reference only — not a dosing instruction.
Keep lyophilized vials frozen and out of light. Once reconstituted, refrigerate (2–8 °C) and use within a few weeks. Always use sterile technique.
For laboratory and research use only. Not for human or veterinary use, food, or drug applications.